Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28926 - 28950 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Darinaparsin	Investigational	PMAIP1	5366	upregulated	darinaparsin results in increased expression of PMAIP1 mRNA	18q21.32	A20755
Darinaparsin	Investigational	SEMA4B	10509	downregulated	darinaparsin results in decreased expression of SEMA4B mRNA	15q25	A20760
Darinaparsin	Investigational	SERPINE1	5054	upregulated	darinaparsin results in increased expression of SERPINE1 mRNA	7q22.1	A20760
Darinaparsin	Investigational	SMPD1	6609	upregulated	darinaparsin results in increased expression of SMPD1 mRNA	11p15.4	A20760
Darinaparsin	Investigational	TAGLN	6876	upregulated	darinaparsin results in increased expression of TAGLN mRNA	11q23.2	A20760
Darinaparsin	Investigational	TGFA	7039	downregulated	darinaparsin results in decreased expression of TGFA mRNA	2p13.3	A20760
Darinaparsin	Investigational	TGFB2	7042	upregulated	darinaparsin results in increased expression of TGFB2 mRNA	1q41	A20760
Darinaparsin	Investigational	TXNRD1	7296	upregulated	darinaparsin results in increased expression of TXNRD1 mRNA	12q23.3	A20834
Darinaparsin	Investigational	UPP1	7378	upregulated	darinaparsin results in increased expression of UPP1 mRNA	7p12.3	A20760
Dasatinib	Approved Investigational	A2M	2	upregulated	Dasatinib results in increased expression of A2M mRNA	12p13.31	A21899
Dasatinib	Approved Investigational	ABCA1	19	upregulated	Dasatinib results in increased expression of ABCA1 mRNA	9q31.1	A21899
Dasatinib	Approved Investigational	ABCC3	8714	upregulated	Dasatinib results in increased expression of ABCC3 mRNA	17q21.33	A21899
Dasatinib	Approved Investigational	ABHD4	63874	upregulated	Dasatinib results in increased expression of ABHD4 mRNA	14q11.2	A21899
Dasatinib	Approved Investigational	ACAN	176	upregulated	Dasatinib results in increased expression of ACAN mRNA	15q26.1	A21899
Dasatinib	Approved Investigational	ACTA2	59	upregulated	Dasatinib results in increased expression of ACTA2 mRNA	10q23.31	A21899
Dasatinib	Approved Investigational	ACTC1	70	upregulated	Dasatinib results in increased expression of ACTC1 mRNA	15q14	A21899
Dasatinib	Approved Investigational	ACTG2	72	upregulated	Dasatinib results in increased expression of ACTG2 mRNA	2p13.1	A21899
Dasatinib	Approved Investigational	ADAMTS5	11096	upregulated	Dasatinib results in increased expression of ADAMTS5 mRNA	21q21.3	A21899
Dasatinib	Approved Investigational	AK5	26289	downregulated	Dasatinib results in decreased expression of AK5 mRNA	1p31.1	A21899
Dasatinib	Approved Investigational	AKR1C3	8644	upregulated	Dasatinib results in increased expression of AKR1C3 mRNA	10p15.1	A21899
Dasatinib	Approved Investigational	ALDH1A1	216	upregulated	Dasatinib results in increased expression of ALDH1A1 mRNA	9q21.13	A21899
Dasatinib	Approved Investigational	ALDH1L2	160428	upregulated	Dasatinib results in increased expression of ALDH1L2 mRNA	12q23.3	A21899
Dasatinib	Approved Investigational	ALDH2	217	upregulated	Dasatinib results in increased expression of ALDH2 mRNA	12q24.12	A21899
Dasatinib	Approved Investigational	ALPK2	115701	upregulated	Dasatinib results in increased expression of ALPK2 mRNA	18q21.31-q21.32	A21899
Dasatinib	Approved Investigational	AMIGO2	347902	upregulated	Dasatinib results in increased expression of AMIGO2 mRNA	12q13.11	A21899

Displaying entries 28926 - 28950 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability